Janssen-Cilag Farmaceutica
Part of Johnson & Johnson
CompanyBrazilFounded 1982
Janssen-Cilag Farmaceutica develops one asset, in phase 3, no development reported (Norelgestromine (NLGM)/ethinyl estradiol (EE) in contraception). Mostly small molecule; based in Brazil, founded in 1982.
- 1
- Asset
- Furthest stage
- Phase 3, no development reported
- 3
- Trials
- 0
- Signals
Pipeline
1Norelgestromine (NLGM)/ethinyl estradiol (EE)
Activates progesterone and estrogen receptors to suppress ovulation and prevent pregnancy.
Phase 3, no development reported, Small molecule, contraception
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials4
- Similar companies6